Get the Stockscreener App
1.82
0.55%
0.01
Sana Biotechnology Inc stock is traded at $1.82, with a volume of 4.86M.
It is up +0.55% in the last 24 hours and up +17.42% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$1.81
Open:
$1.68
24h Volume:
4.86M
Relative Volume:
1.52
Market Cap:
$426.15M
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-1.2381
EPS:
-1.47
Net Cash Flow:
$-273.61M
1W Performance:
-3.70%
1M Performance:
+17.42%
6M Performance:
-39.43%
1Y Performance:
-75.73%
1-Day Range:
$1.68
$1.96
1-Week Range:
$1.67
$1.96
52-Week Range:
$1.26
$9.49
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.82 | 426.15M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Sana: Q1 Earnings Snapshot - New Haven Register
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Optimistic Buy Rating for Sana Biotechnology Amid Promising Clinical Developments and Stable Financial Outlook - TipRanks
2025-05-08 | Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA | NDAQ:SANA | Press Release - Stockhouse
Sana Biotechnology Enters New $119M Sales Agreement - TipRanks
SANA LAWSUIT ALERT: Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class ... - Bluefield Daily Telegraph
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - Finansavisen
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – SANA - TradingView
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - PR Newswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Marshall Wace LLP - Defense World
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Shareholders that lost money on Sana Biotechnology, Inc. (SANA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana ... - Bluefield Daily Telegraph
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - PR Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Lost Money on Sana Biotechnology, Inc.(SANA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Renaissance Technologies LLC - Defense World
Comparing Sana Biotechnology (NASDAQ:SANA) & Aptose Biosciences (NASDAQ:APTO) - Defense World
Sana Biotechnology Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - PR Newswire
Shareholders that lost money on Sana Biotechnology, Inc. - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - The Malaysian Reserve
Sana Biotechnology Inc [SANA] Records 50-Day SMA of $2.1365 - knoxdaily.com
Shareholders that lost money on Sana Biotechnology, Inc. (SANA) should contact The Gross Law - Bluefield Daily Telegraph
Sana Biotechnology Inc (SANA) Stock: A Year of Stock Market Dynamics - investchronicle.com
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc.(SANA) - Finansavisen
Press Release Distribution & PR Platform - ACCESS Newswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sana - GlobeNewswire
Healthy Upside Potential: Sana Biotechnology Inc (SANA) - Sete News
Sana Biotechnology Inc (SANA) presents a great opportunity, but the stock is slightly undervalued - uspostnews.com
Citizens JMP upgrades Sana Biotechnology Inc (SANA) stock to a Mkt outperform - knoxdaily.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - ACCESS Newswire
SANA LAWSUIT ALERT: The Gross Law Firm Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Kilgore News Herald
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to - Bluefield Daily Telegraph
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Sells 110,538 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Class Action Filed Against Sana Biotechnology, Inc. (SANA)May 20, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Sana Biotechnology Inc (SANA) Stock: A Year of Decreases and Increases - investchronicle.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sana Biotechnology Inc Stock (SANA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):